Chendil D, Oakes R, Alcock R A, Patel N, Mayhew C, Mohiuddin M, Gallicchio V S, Ahmed M M
Department of Radiation Medicine, College of Medicine, University of Kentucky, Lexington, Kentucky, USA.
Cancer. 2000 Nov 1;89(9):1893-900. doi: 10.1002/1097-0142(20001101)89:9<1893::aid-cncr4>3.3.co;2-2.
The current study was undertaken to investigate the influence of wild-type or mutant p53 status on the radiosensitizing effect of paclitaxel in colorectal tumor cell lines.
HCT-116 (contains wild-type p53) and HT-29 (contains mutant p53) established from moderately differentiated colorectal carcinomas were used in this study. Colony-forming assay was performed after exposure to either different radiation doses (0.5-6 gray [Gy]) or paclitaxel (1-10 nM) or in combination. Induction of p53 and p21(waf1/cip1) by these treatments were determined by immunocytochemistry and Western blot analysis.
Radiation caused an increase in nuclear p53 and p21(waf1/cip1) proteins in HCT-116 cells, indicating that p53 functionally induced p21(waf1/cip1). However, induction of nuclear p53 and p21(waf1/cip1) protein was not evident in HT-29 cells, suggesting that p53 was not functional in these cells. Survival data showed that the HCT-116 cells (survival fraction of exponentially growing cells that were irradiated at the clinically relevant dose of 2 Gy [SF(2)] = 0.383; dose required to reduce the fraction of cells to 37% [D(0)] = 223 centigray [cGy]) were significantly sensitive to ionizing radiation (P < 0.008) when compared with the HT-29 cells (SF(2) = 0.614; D(0) = 351 cGy). Paclitaxel caused a higher degree of clonogenic inhibition in HCT-116 (D(0) = 0.7 nM) than HT-29 (D(0) = 1.11 nM) cells (P < 0.06). When paclitaxel and radiation were combined, an enhanced radiosensitizing effect (P < 0.05) was observed in HCT-116 cells (SF(2) = 0.138; D(0) = 103 cGy), whereas in HT-29 cells no significant radiosensitization of paclitaxel was observed (SF(2) = 0.608; D(0) = 306 cGy). However, pretreatment with paclitaxel followed by multifractionated low dose radiation (0.5- or 1-Gy fractions for a total dose of 2 Gy) significantly enhanced the radiosensitizing effect in both HCT-116 and HT-29 cells.
The results of the current study suggested that multifractionated radiation given at very low doses after exposure of cells to paclitaxel conferred a potent radiation sensitizing effect irrespective of p53 status.
本研究旨在探讨野生型或突变型p53状态对结直肠肿瘤细胞系中紫杉醇放射增敏作用的影响。
本研究使用了从中度分化的结直肠癌建立的HCT-116(含野生型p53)和HT-29(含突变型p53)细胞系。在暴露于不同辐射剂量(0.5 - 6戈瑞[Gy])、紫杉醇(1 - 10纳摩尔)或两者联合后进行集落形成试验。通过免疫细胞化学和蛋白质印迹分析确定这些处理对p53和p21(waf1/cip1)的诱导作用。
辐射导致HCT-116细胞中核p53和p21(waf1/cip1)蛋白增加,表明p53功能性地诱导了p21(waf1/cip1)。然而,HT-29细胞中核p53和p21(waf1/cip1)蛋白的诱导不明显,提示p53在这些细胞中无功能。生存数据显示,与HT-29细胞(SF(2)=0.614;D(0)=351厘戈瑞[cGy])相比,HCT-116细胞(指数生长细胞在临床相关剂量2 Gy照射后的存活分数[SF(2)] = 0.383;将细胞分数降低至37%所需的剂量[D(0)] = 223厘戈瑞[cGy])对电离辐射更敏感(P < 0.008)。紫杉醇对HCT-116细胞(D(0)=0.7纳摩尔)的克隆抑制程度高于HT-29细胞(D(0)=1.11纳摩尔)(P < 0.06)。当紫杉醇与辐射联合时,在HCT-116细胞中观察到增强的放射增敏作用(P < 0.05)(SF(2)=0.138;D(0)=103 cGy),而在HT-29细胞中未观察到紫杉醇的显著放射增敏作用(SF(2)=0.608;D(0)=306 cGy)。然而,先用紫杉醇预处理,然后进行多分割低剂量辐射(0.5 - 或1 - Gy分割,总剂量为2 Gy),在HCT-116和HT-29细胞中均显著增强了放射增敏作用。
本研究结果表明,细胞暴露于紫杉醇后给予极低剂量的多分割辐射可产生有效的放射增敏作用,与p53状态无关。